Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer Article

Vergote, Ignace, Finkler, Neil J, Hall, James B et al. (2010). Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 20(5), 772-780. 10.1111/IGC.0b013e3181daaf59

International Collaboration

cited authors

  • Vergote, Ignace; Finkler, Neil J; Hall, James B; Melnyk, Ostap; Edwards, Robert P; Jones, Marsha; Keck, James G; Meng, Lisa; Brown, Gail L; Rankin, Elaine M; Burke, James J; Boccia, Ralph V; Runowicz, Carolyn D; Rose, Peter G

sustainable development goals

authors

publication date

  • July 1, 2010

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • Phase 3 clinical trial
  • Platinum resistant
  • Science & Technology
  • TOPOTECAN

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 772

end page

  • 780

volume

  • 20

issue

  • 5